Goldman Sachs Group Inc A Tyr Pharma Inc Transaction History

Goldman Sachs Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.42 - $2.02 $104,601 - $148,799	73,663 Added 51.31%	217,233 $423,000
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.51 $159,362 - $216,790	143,570 New	143,570 $202,000
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $87,932 - $139,580	-18,512 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.29 - $9.5 $134,952 - $175,864	18,512 New	18,512 $138,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.